Position in BNTX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$71,903
-$5,113 QoQ
Shares Held
809
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Crewe Advisors LLC holds $1,045,793 across 17 Biotechnology names. BNTX ranks #3 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NAUT |
Nautilus Biotechnology, Inc.
|
136,052 | $527,881 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
500 | $223,270 | |
| 3 | BNTX |
BioNTech SE
This page
|
809 | $71,903 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
1,999 | $37,781 | |
| 5 | MRNA |
Moderna, Inc.
|
726 | $36,880 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
181 | $36,136 | |
| 7 | ASBP |
Aspire Biopharma Holdings, Inc.
|
20,335 | $20,945 | |
| 8 | MNKD |
Mannkind Corp
|
8,074 | $19,781 |
All Filings in BNTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $71,903 | 809 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $77,016 | 809 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $79,783 | 809 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $86,134 | 809 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $73,667 | 809 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $92,185 | 809 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $96,084 | 809 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $65,011 | 809 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $74,630 | 809 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||